Syndax Pharmaceuticals (SNDX) Interest Expenses (2020 - 2025)
Syndax Pharmaceuticals (SNDX) recorded quarterly Interest Expenses of $4000.0 in Q2 2025, up 100.0% quarter-over-quarter from $2000.0 in Q1 2025, and down 91.11% on a YoY basis from $45000.0 in Q2 2024.
Syndax Pharmaceuticals (SNDX) Interest Expenses (2020 - 2025) Analysis & Trends
Syndax Pharmaceuticals' Interest Expenses history runs 6 years deep, the most recent figure standing at $4000.0 for Q2 2025.
- In Q2 2025, Interest Expenses fell 91.11% year-over-year to $4000.0; the TTM figure through Mar 2026 stood at $4000.0 (up 107.41% YoY), while the FY2025 annual figure was $6000.0, up 700.0% from the prior year.
- Interest Expenses was $4000.0 for Q2 2025 at Syndax Pharmaceuticals, up from $2000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1.7 million in Q3 2022 to a low of -$124000.0 in Q4 2024.
- Historically, Interest Expenses has averaged $293388.9 across 5 years, with a median of $54000.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses surged 714.29% in 2022, then plunged 296.83% in 2024.
- A 5-year view of Interest Expenses shows it stood at -$7000.0 in 2021, then jumped by 714.29% to $43000.0 in 2022, then jumped by 46.51% to $63000.0 in 2023, then slumped by 296.83% to -$124000.0 in 2024, then jumped by 103.23% to $4000.0 in 2025.
- The last three Interest Expenses figures came in at $4000.0 (Q2 2025), $2000.0 (Q1 2025), and -$124000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Syndax Pharmaceuticals | 1.69 Bn | 1.34 Bn | 53.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -124,000.00 |
| Dec 31, 2024 | -124,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 45,000.00 |
| Jun 30, 2024 | 45,000.00 |
| Mar 31, 2024 | 87,000.00 |
| Mar 31, 2024 | 87,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Sep 30, 2023 | 70,000.00 |
| Sep 30, 2023 | 70,000.00 |
| Jun 30, 2023 | 35,000.00 |
| Jun 30, 2023 | 35,000.00 |
| Mar 31, 2023 | 40,000.00 |
| Mar 31, 2023 | 40,000.00 |